Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.470
-0.100 (-2.19%)
Apr 16, 2026, 4:00 PM EDT - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $261.59 million as of April 16, 2026. Its market cap has increased by 110.73% in one year.
Market Cap
261.59M
Enterprise Value
170.45M
1-Year Change
110.73%
Ranking
Category
Stock Price
$4.47
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $261.59M, an increase of 32.49%. That is a compound annual growth rate of 5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 261.59M | 11.63% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 277.45M |
| Cybin | 273.20M |
| Compugen | 272.32M |
| SAB Biotherapeutics | 271.26M |
| Coherus Oncology | 269.80M |
| C4 Therapeutics | 269.32M |
| Alector | 265.97M |
| Minerva Neurosciences | 254.02M |